: In order to
A. Prediction of obliteration
The first report of an AVM obliteration following GK surgery was published in 19721). It was a case report of a patient treated with "gamma ligation". The rationale was to ligate the feeders, and it was performed by using one isocenter directed towards the feeding artery. An angiography 19 month later revealed total obliteration. This case was followed by others treated with the same philosophy, but the results were not satisfactory2). The treatment strategy was, when possible, therefore changed to radiation of the whole AVM nidus volume. In 1984 Steiner reported the results following different treatment strategies3). The report was based on angiography follow ups in 192/ 300 (64%) of the patients, and the treatments divided into four groups A : total ; and B : partial radiation cover of the nidus. C : coverage of all ; and D : some feeders. The two years angiography follow up results were : 90/104, (86%) obliteration in group A ; 0/10 in group B ; 1/3 in group C and 0/4 in group D. The definition of the two years angiography follow up being the endpoint to evaluate the treatment result has since become generally accepted for radiosurgery. The result in group A, 80% obliteration rate, has also been accepted as what can be expected following optimal radiosurgery. The results above has also been used to support the opinion that larger malformations are less likely to obliterate following radiosurgery, although this was not expressed in the publication.
The Pittsburgh group published their first major AVM publication in 19914). Of 227 patients treated, 46 (20%) were followed up with a two-year angiography. They concluded that the results are AVM volume dependent, i.e. the obliteration rate decreased with an increasing AVM volume. They also recently published a model to predict the probability of obliteration following radiosurgery for AVM5).
The opinion that the AVM size has an independent importance for the outcome is also represented in another publicationo. Recently Schwarz et al pooled their own data with the Sheffield data, and related the outcome to a prediction model based on the assumption that the chance for cure is related to the lowest periphery dose (Dmin) and the largest AVM nidus diameter.
Recently, the first 20 years of experience following GK treatments of AVM at the Karolinska and University of Virginia was analyzed7,8. Two models to predict the probability of obliteration were published, one based on Dmin only and the other on Dmin and the average radius of the AVM nidus.
A model has to predict the probability for obliteration reasonable accurate before the treatment in every case. If this is the case, than the model also has the ability to accurately predict the number of obliterations in a group of patients, independent of how the group is selected. We can therefore check the accuracy of the model by comparing the predicted with the observed number of obliteration in different subgroups of patients in a large patient material. This was done by comparing the predictions to the outcome in different subgroups of the 830 AVMs with adequate follow up out of 1033 treated with Gamma Knife surgery at the Karolinska Hospital 1970-1993. where P = the probability for obliteration (%). This model predicts the probability for obliteration accurately for the whole patient material. In addition, it accurately predicts the probability for small or large AVM treated with high or low doses. Furthermore, age, gender, maximum dose, average dose, AVM location, previous treatment and history of bleeding does not affect the accuracy of the prediction9). Therefore, it seems that the model above is accurate and can be used to predict the treatment results prior to the treatment. It can also be used to predict the probability for obliteration when treating previously irradiated malformations'°.
Both the observation that the result of the prediction is independent of the AVM volume and the observation that a previous treatment, resulting in a size decrease of the AVM, does not affect the accuracy of the prediction model strongly indicate that the probability for obliteration is dose dependent only. The AVM volume itself does not directly affect the treatment results, only indirectly, as a larger malformation is usually treated with a lower dose of radiation in order to keep the risk for complications at an acceptable level.
B. Prediction of the risk for complications
The limiting factor in radiosurgery is the risk for suffer from radiation induced complications. Flickinger published in 1989 an integral logistic formula for prediction of complications in radiosurgery12). This model was based on information from the literature, and it has been used to predict a 3 % probability for brain necrosis following radiosurgery treatment of acoustic neuromas13), meningiomas14), and AVMs4). The Pittsburgh group has now abandoned the concept that one risk estimation model can be used for different diagnoses15). A more accurate risk prediction model is possible to determine by using the dose distributions and other data from a large patient material.
We therefore decided to analyze all AVM patients treated at the Karolinska Hospital 1970-April 1992. A total of 862 patients were eligible for and included in the study. It could be shown that the only factor related to the incidence of complications was the average dose to the radiated volume, including both the target and the brain volume adjacent to the target16). Based on this finding, a risk estimation model was determined which could predict the risk for complications prior to the treatment ' 6) It is obvious that a complication occurs from the brain tissue and not from the pathology treated. It can therefore be argued that it is only the radiation delivered to the brain tissue, and not to the target volume, that is of importance for the risk for complications. This concept was used in the integral logistic formula12).
We did not believe that this was accurate. We felt that a complication may also be caused by the indirect effects of the radiation, such as swelling, changed microcirculation, increased local pressure etc."). If so, the amount of radiation to the target volume is also of interest. We therefore calculated the average dose in a volume large enough to cover both the target volume and the surrounding brain volume receiving a high dose of radiation, and we arbitrarily chose 20cm3 as this volume. It could be shown that the average dose in this volume was related to the incidence of complications. The Pittsburgh group have now accepted our philosophy, and the now agree with the concept that all radiation delivered is of importance for the risk for complications15).
Using the same concept as in the previous paragraph (A), the accuracy of the model was checked by comparing the observed with the predicted number of complications in different subgroups of the material, and thereby define if any other factor than the dose distribution is of importance for the risk for complications. This was done in a patient material of 1128 patients treated in a 24 years period17).
It could be shown that previous radiation given increases the risk for complications10,17. It could also be shown that a central location increases the risk for complications, and that a previous hemorrhage decreases the risk. The latter was not detected when a multivariance analysis was performed, the reason being that 90% of the centrally located malformations have a hemorrhage as the initial symptom. However, when central and peripheral AVM were analyzed separately, the impact of a previous hemorrhage became obvious for peripheral AVM.
It is obvious that one risk estimation model cannot accurately predict the risk for complications in all AVMs, but that at least three models are needed. It is equally obvious that a risk estimation model based on the results following AVM treatments cannot directly be used to predict the risk for complications when other pathologies are treated. In this matter, there was previous a disagreement between the Karolinska and Pittsburgh group.
When we published our first risk estimation model, a caveat was given to use it for other diagnoses than AVM"). One example hereof is the around 8 times higher risk seen when cavernous malformations are treated18). The Pittsburgh group recommended earlier the use of the integral logistic modeP2) for all diagnoses4,13,4), but in their latest paper they agree with our opinion and write that the risk is different for different diagnoses15).
The fact that the Pittsburgh group, after having compared the predicted and observed outcome in their own patient material, has accepted and agreed to the concepts published earlier by us makes the probability high that our risk estimation model is reasonable accurate. This is, however, of little help for a radiosurgery center if they cannot use the model when treating their own patients. A reasonable accurate estimation can be obtained by using the graph in figure 1 , where the average dose to 20cm3 is plotted against the risk for complications for different AVM locations.
A more accurate prediction can be obtained by using the software written by us that is presently used at the Karolinska Hospital and the Gamma Knife centers in Miinchen, San Diego and Madrid. This software can easily be implemented in the GammaPlan, and it can be obtained from one of the authors (Lax to compare the pre-and post treatment incidence for hemorrhage, just to estimate the magnitude of the risk itself, and the factors influencing it. This information is available in one of our papers, from which the following is extracted21. The time period studied was the first two years following the GK treatment in 1604 consecutive patients. All hospital records of the patients were studied. In 1403/1604 patients (87%), the result of a post treatment radiology examination was known. For the remaining 201 cases letters were sent and phone calls made, resulting in information from most, but not all, of the patients. It could be argued that the patients lost to any kind of follow up did suffer from a lethal hemorrhage. If so, the percentage of patients reported dying from a hemorrhage in this series would have been lower than expected. This was not the case. In the series, 29% of the patient with rupture died due to the hemorrhage. This is within the range previously reported, 20 to 41%4,11,22-25).
To investigate if any factors could be related to the incidence of post treatment rupture, a number of parameters, listed in table 1, were analyzed. Age at treatment, AVM volume, Dmin and average dose significantly correlated to the incidence of hemorrhage, which was higher in older patients and larger AVM. It was lower when higher average doses or higher doses to the AVM periphery were used. In other words, if the whole malformation was included in the radiation field a lower post treatment incidence of hemorrhage was observed. Due to the fact that the three parameters AVM volume, Dmin and average dose are interdependent a multivariance analyze was performed. The P-values were 0.95 ; 0.12 and 0.24, respectively. Thus, Dmin seems to be the major decisive parameter.
The median time between initial hemorrhage and GK treatment was 8 months (one week-36.3 years, mean 2.5 years). There was no significant correlation between incidence of post treatment hemorrhage and time elapsed between the presenting hemorrhage and treatment (P = 0.85).
The risk of post treatment hemorrhage is illustrated in figure 2 . The material is divided according to Dmin, and it is obvious that the risk for hemorrhage increases with decreasing Dmin. Based on this graph, an estimation of the total risk for post treatment hemorrhage can be calculated, assuming a two years delay between treatment and obliteration. bleeding, and an exponential fit for the two other. For clarity, the 95% confidence interval bars are plotted for centrally located AVM only, but they are in the same magnitude for the two other groups . Larger AVM volume and high age of the patient are both related to a higher risk for hemorrhage, while a high average and a high minimum dose both decrease the risk for hemorrhage. Fig. 2 Annual risk for hemorrhage per 6 months period after the treatment. The area marked with///represents the risk for hemorrhage in untreated patients. By using this graph, the risk for post treatment hemorrhage can be calculated.
